Skip to main content

Animations

MJFF Publications

2441 - 2450 of 6422 Results
Title
Year
  • Year
  • 2024
  • 2024
  • 2022
  • 2022
  • 2024
  • 2024
  • 2024
  • 2021
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: Novel Variants Linked to the Prodromal Stage of Parkinson’s Disease (PD) Patients
    Journal Name: Diagnostics
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/diagnostics14090929
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Genome sequence analyses identify novel risk loci for multiple system atrophy
    Journal Name: Neuron
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.neuron.2024.04.002
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Subcellular proteomics of dopamine neurons in the mouse brain
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.7554/elife.70921
    Citation Count: 52
  • Summary Details
    OPEN
    Title: Therapeutic deep brain stimulation disrupts movement-related subthalamic nucleus activity in parkinsonian mice
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.7554/elife.75253
    Citation Count: 40
  • Summary Details
    OPEN
    Title: SVA Regulation of Transposable Element Clustered Transcription within the Major Histocompatibility Complex Genomic Class II Region of the Parkinson’s Progression Markers Initiative
    Journal Name: Genes
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/genes15091185
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Evaluation of Cerebrospinal Fluid α‐Synuclein Seed Amplification Assay in Progressive Supranuclear Palsy and Corticobasal Syndrome
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/mds.30019
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Viral overexpression of human alpha-synuclein in mouse substantia nigra dopamine neurons results in hyperdopaminergia but no neurodegeneration
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2024.114959
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Miro1 Impairment in a Parkinson’s At-Risk Cohort
    Journal Name: Frontiers in Molecular Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnmol.2021.734273
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Semantic Integration of Multi-Modal Data and Derived Neuroimaging Results Using the Platform for Imaging in Precision Medicine (PRISM) in the Arkansas Imaging Enterprise System (ARIES)
    Journal Name: Frontiers in Artificial Intelligence
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/frai.2021.649970
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Multi-predictor modeling for predicting early Parkinson’s disease and non-motor symptoms progression
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2022.977985
    Citation Count: 5
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.